0001200876-22-000025.txt : 20220504 0001200876-22-000025.hdr.sgml : 20220504 20220504081738 ACCESSION NUMBER: 0001200876-22-000025 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 EFFECTIVENESS DATE: 20220504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xenetic Biosciences, Inc. CENTRAL INDEX KEY: 0001534525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452952962 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-444330 FILM NUMBER: 22889905 BUSINESS ADDRESS: STREET 1: 40 SPEEN STREET, SUITE 102 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 781-778-7720 MAIL ADDRESS: STREET 1: 40 SPEEN STREET, SUITE 102 CITY: FRAMINGHAM STATE: MA ZIP: 01701 FORMER COMPANY: FORMER CONFORMED NAME: General Sales & Leasing, Inc. DATE OF NAME CHANGE: 20130227 FORMER COMPANY: FORMER CONFORMED NAME: GENERAL AIRCRAFT INC. DATE OF NAME CHANGE: 20111108 D 1 primary_doc.xml X0708 D LIVE 0001534525 Xenetic Biosciences, Inc. 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA MASSACHUSETTS 01701 781-778-7720 NEVADA General Sales & Leasing, Inc. GENERAL AIRCRAFT INC. Corporation true Jeffrey Eisenberg 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Executive Officer Director Chief Executive Officer James Parslow 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Financial Officer Adam Logal 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director Curtis Lockshin 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Science Officer Grigory Borisenko 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director James Callaway 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director Firdaus Dastoor 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director Alexey Vinogradov 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director Roger Kornberg 40 Speen Street, Suite 102 Framingham MA MASSACHUSETTS 01701 Director Biotechnology $1,000,001 - $5,000,000 06b false 2022-04-26 false true true Up to 950,000 Common Shares (equity) may be issued in the future if certain regulatory milestones are achieved under various license agreements, which may not occur. false 0 866250 866250 0 Up to 950,000 Common Shares (equity) may be issued in the future if certain regulatory milestones are achieved under various license agreements, which may not occur. Such amount cannot be calculated at this time. false 2 0 0 0 false Xenetic Biosciences, Inc. /s/James Parslow James Parslow CFO 2022-05-03